Walgreen Boots Stock Price, News & Analysis

Walgreens Boots Alliance (WBA) reported Q2 fiscal 2022 earnings with an EPS of $1.02, down from $1.06 a year ago. However, adjusted EPS rose 25.9% to $1.59. Sales from continuing operations increased 3.0% to $33.8 billion, driven by strong performance in U.S. retail and COVID-19 services. Operating income rose significantly to $1.2 billion, while net earnings were $883 million, down from $922 million year-over-year. The company is progressing with its Boots business review and expects annual savings of $3.3 billion by 2024.

Walgreens Boots Alliance (WBA) and VillageMD are set to launch three new Village Medical at Walgreens primary care practices in Southern New Hampshire by the end of summer 2022. The first location opens on April 19 in Hooksett, with additional sites in Manchester and Nashua. This initiative will create over 80 full-time jobs, including 35 STEM positions. The partnership aims to enhance accessible healthcare for local communities, addressing significant gaps in coverage. WBA plans to expand to over 600 practices nationwide by 2025, reinforcing its commitment to community health.

Tripadvisor has partnered with Walgreens to promote safe travel during spring break, emphasizing COVID-19 testing access for travelers. This initiative targets college students and families, showcasing Walgreens' drive-thru COVID-19 testing and vaccination options. A Tripadvisor survey reveals 45% of Americans plan to travel in March and April, with 68% of Gen Z intending to get tested. As travel demand grows, 62% of Americans prefer businesses with COVID-19 safety measures. This partnership highlights a strategic move to capture digital media advertising amid increasing travel activity.

Walgreens and Labcorp have launched the nationwide availability of the Pixel by Labcorp® COVID-19 at-home collection kit, accessible at no cost to eligible individuals via Labcorp OnDemand™. This initiative, in partnership with the U.S. Department of Health and Human Services, aims to enhance testing accessibility for underserved communities. Walgreens President John Standley emphasized the importance of reducing healthcare barriers, particularly for uninsured populations. The program complements Walgreens' existing free drive-thru testing at over 7,000 locations and contributes to broader healthcare efforts amidst evolving COVID-19 conditions.

The UK’s leading skincare brand, No7, has shown superior hydration results in a recent study compared to pricier competitors in the US. Specifically, its age defying day creams outperform moisturizers costing ten times more. This follows a successful UK sales record, with one cream sold every ten seconds in 2021. The brand's new marketing campaign, "The UK’s Best-Kept Skincare Secret," aims to establish a stronger presence in the US market. Additionally, No7 is launching more sustainable packaging and a consumer-focused challenge to demonstrate product efficacy.

Walgreens Boots Alliance (WBA) will announce its fiscal 2022 Q2 earnings results on March 31, 2022, at 7 a.m. Eastern Time, followed by a management conference call at 8:30 a.m. The call will be accessible via the WBA investor relations website and will be archived for 12 months. WBA operates approximately 13,000 locations across the US, Europe, and Latin America, focusing on integrated healthcare and retail pharmacy services. The company is recognized for its sustainable practices and its commitment to creating healthier communities.

Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD have announced the opening of five new Village Medical at Walgreens practices in the Jacksonville area. This initiative aims to enhance healthcare accessibility and will create over 295 new jobs, including 100 in STEM fields. The first practice opens on February 15, 2022. This expansion follows recent openings in Orlando and Tampa, solidifying their presence in the Florida market.

Walgreens Advertising Group has announced new self-serve programmatic and clean-room solutions for brand advertisers. These solutions enable advertisers to utilize Walgreens' first-party data on their chosen demand-side platforms (DSPs). The offerings aim to enhance campaign management and deliver personalized ads, leveraging over 95 million myWalgreens members and 1 billion daily touchpoints. Advertisers will access these solutions in Q2, optimizing campaigns through closed-loop reporting. Customer privacy remains a priority, featuring data confidentiality within the new service.